Ramsay Health Care trial finds first-line catheter ablation improves outcomes in ventricular tachycardia patients

• Ramsay Health Care flagged CAAD-VT trial results showing first-line catheter ablation may improve outcomes for ventricular tachycardia patients.
• Data were already presented as a Late Breaking Clinical Trial at the Heart Rhythm Society Annual Scientific Sessions in Chicago.
• Study compared initial ablation with anti-arrhythmic drugs in a broad, real-world structural heart disease population.
• Findings support earlier intervention to reduce repeat episodes, hospital care needs, treatment escalation, mortality risk.
• Trial recruited across nine Australian sites, positioning the program as potentially practice-changing for cardiology care pathways.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ramsay Health Care Limited published the original content used to generate this news brief on May 27, 2026, and is solely responsible for the information contained therein.